US Edition
Protect Me trial: A groundbreaking study on fetal growth restriction
Summary by Monash Health
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Protect Me trial: A groundbreaking study on fetal growth restriction
In a world-first initiative, the recruitment for the Protect Me trial targeting fetal growth restriction (FGR), a condition in which an unborn baby is smaller than expected, has now been completed. This trial, which began in 2019, explores whether melatonin could be the first therapeutic approach to improving the outcomes of FGR by targeting placental dysfunction. Professor Kirsten Palmer is the Head of Maternal Fetal Medicine at Monash Medical …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
